As the prevalence of diabetes continues to climb, the number of individuals living with
diabetic complications will reach an unprecedented magnitude. The emergence of new …

The combination of obesity and hypertension is associated with high morbidity and mortality
because it leads to cardiovascular and kidney disease. Potential mechanisms linking …

Simple Summary Cardiovascular diseases (CVDs) are the leading causes of death
worldwide. Epicardial adipose tissue (EAT) is one of the most important risk factors for …

COVID-19 outbreak, caused by severe acute respiratory syndrome (SARS)-CoV-2
coronavirus has become an urgent health and economic challenge. Diabetes is a risk factor …

Obesity is an emerging pandemic driven by consumption of a diet rich in fat and highly
refined carbohydrates (a Western diet) and a sedentary lifestyle in both children and adults …

Objective Epicardial adipose tissue (EAT), the visceral fat depot of the heart, is a modifiable
cardiovascular risk factor and emerging therapeutic target. Liraglutide, an analog of …

Epidemiological studies support the notion that arterial stiffness is an independent predictor
of adverse cardiovascular events contributing significantly to systolic hypertension, impaired …

In the United States the prevalence of end-stage renal disease (ESRD) reached epidemic
proportions in 2012 with over 600,000 patients being treated. The rates of ESRD among the …

Background Dipeptidyl peptidase-4 inhibitor (DPP-4i) and renin-angiotensin system (RAS)
blockade are reported to affect the clinical course of coronavirus disease 2019 (COVID-19) …

Highlights•Epicardial fat can be easily measured with imaging procedures.•Epicardial fat
can be a therapeutic target of drugs targeting the adipose tissue.•Epicardial fat responds to …